Covishield, Covaxin vaccines work against Alpha, Beta, Gamma, Delta variants of SARS-CoV-2: Centre
"Covishield and Covaxin work against the variants of SARS-CoV-2- Alpha, Beta, Gamma and Delta -- that is well established for these two vaccines," ICMR Director General said.
Jun 27, 2021, 10:57 AM IST
Pregnant women can be vaccinated against COVID-19, says Union Health Ministry
During the conference, the Director of the National Centre for Disease Control (NCDC) Dr SK Singh informed that a total of 48 cases of Delta Plus variant of COVID-19 coronavirus have been detected in the country so far.
Jun 25, 2021, 21:14 PM IST
Mamata Banerjee writes to PM Narendra Modi, seeks early WHO approval for Covaxin
She also urged the Centre to immediately take steps to ensure that people vaccinated with Covaxin are not restricted from travelling to foreign countries. The Trinamool Congress chief claimed that Covaxin has also created problems with neighbouring Bangladesh and Brazil.
Jun 24, 2021, 16:34 PM IST
66,87,438 people have been vaccinated in Delhi so far, more than 16 lakh received both doses: Atishi
Atishi said, "In Delhi, 84,539 people were administered vaccine doses on June 22. Out of which about 55,000 doses were administered to the youth."
Jun 24, 2021, 14:05 PM IST
Kanpur Dehat's 2-year-old girl gets Covaxin jab, first in Uttar Pradesh
During the ongoing trial of Covaxin on young children in the city, the 2-year-old girl was given the first dose of the indigenous COVID vaccine.
Jun 24, 2021, 09:03 AM IST
Covaxin for children above 2 years to be available by September, says Delhi AIIMS chief Randeep Guleria
Delhi AIIMS chief Dr. Randeep Guleria said that Covaxin's data for children after completion of the Phase 2/3 trials will be available by September and the approval is expected the same month.
Jun 23, 2021, 06:49 AM IST
Bharat Biotech's Covaxin shows 77.8 % efficacy in phase 3 data trial: Sources
The review meeting took place taking before Bharat Biotech`s pre-submission meeting on Wednesday with the World Health Organization (WHO), for the approval for their COVID vaccine `Covaxin`.
Jun 22, 2021, 15:52 PM IST
COVID-19: Bharat Biotech submits Covaxin's Phase III trial data to DCGI, say Govt sources
Bharat Biotech's phase III data of its vaccine have been questioned various times.
Jun 22, 2021, 08:45 AM IST
Delhi has 2 days of Covaxin, 14 days of Covishield: AAP MLA Atishi urges youth to get COVID jab
"The youth of Delhi must come forward and book their vaccination slots through the CoWin application," AAP MLA Atishi said.
Jun 20, 2021, 14:10 PM IST
COVID-19: Covaxin trial on children aged 12-18 years in Nagpur shows positive signs
No side effects were observed in the children who participated in the Nagpur Center Vaccination Trial even after 1 week. On June 6, 40 volunteers were given the first dose of the Covaxin.
Jun 17, 2021, 14:12 PM IST
Bharat Biotech-WHO pre-submission meeting for Covaxin EUL on June 23
Bharat Biotech had informed that it had submitted 90 per cent of the documentation needed for WHO`s EUL.
Jun 17, 2021, 11:27 AM IST
DNA: Congress leaders spread another "fake news" about Covaxin
Congress leader Gaurav Pandhi on Tuesday made a sensational claim about a component of Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research. Sharing an RTI document on his Twitter account, the Congress leader claimed that Covaxin contains newborn calf serum. After which the Center clarified on this.
Jun 16, 2021, 22:40 PM IST
Half of vaccine centers for youth between 18-44 closed down today in Delhi: Atishi
Only 31,000 vaccine doses are left for the youth of 18-44 years in Delhi, less than 1-day stock is available. The pace of vaccination of youth in Delhi has started slowing down again. Appeal to the Central Government to provide the vaccine to the youth of Delhi at the earliest.
Jun 16, 2021, 21:57 PM IST
No newborn calf serum in Covaxin, Centre busts myth
Covaxin does not contain newborn calf serum at all and the calf serum is not an ingredient of the final vaccine product, the Union Health Ministry said.
Jun 16, 2021, 14:20 PM IST
Bharat Biotech: Providing Covaxin for ₹150/dose to the govt is not possible in the long run
Covaxin, the Coronavirus vaccine, maker Bharat Biotech on Tuesday said the price of Covaxin supplied to the Indian government at ₹150 per dose is a non-competitive price and is not sustainable in the long run and requires a higher price to offset part of the cost.
Jun 15, 2021, 16:36 PM IST
Rs 150 per dose not sustainable: Bharat Biotech demands higher price for Covaxin from Centre
Bharat Biotech has so far invested over Rs 500 crores at risk from its own resources for product development, clinical trials and setting up of manufacturing facilities for Covaxin.
Jun 15, 2021, 14:38 PM IST
Vaccination: Preparation for trial of Covaxin on children
Enrollment for testing of Covaxin on children will be started at AIIMS from today. This enrollment will be for children of the age group of 6 to 12 years. The first dose of the vaccine has already been given to 12-18-year-olds.
Jun 15, 2021, 09:28 AM IST
Bharat Biotech gets CISF security cover at its Hyderabad unit
A unit comprising 64 personnel has been sanctioned that will be headed by an Inspector rank officer.
Jun 14, 2021, 20:15 PM IST
COVID-19: Bharat Biotech ready for Covaxin's clinical trial in US
The full data from studies on Covaxin's neutralisation of variants are already published.
Jun 12, 2021, 22:39 PM IST
Vaccinating 30% big achievement, herd immunity still long way for Delhi, says AAP MLA Atishi
For the 18-44 age group, a total of 1,00,000 doses of vaccines are available including 33,000 Covaxin and 67,000 Covishield jabs.
Jun 12, 2021, 21:53 PM IST
